Incidence of four major osteoporotic fragility fractures among older individuals in Sado, Japan, in 2020.
Norio ImaiAsami NozakiYugo ShobugawaKentaro HiguchiYoshihiro SudaTakeo OinumaHayato SuzukiYoji HorigomeHiroyuki KawashimaPublished in: Journal of bone and mineral metabolism (2024)
The 2020 incidence of the four fractures did not decrease, and the percentage of patients receiving anti-osteoporotic agents did not increase. A higher frequency of osteoporosis treatment is necessary to reduce the incidence of fragility fractures. We recommend using anti-osteoporotic agents to prevent hip fractures among individuals in their mid-70 s and above.